Press Statement For Immediate Release
Friday, April 1, 2016
Global Action Against Pharma Greed
We are not fooled: Global health activists confront pharmaceutical industry over excessive medicine prices
On 1st April 2016, activists across the world are protesting against the greed that blocks access to essential medicines.
April Fools’ Day is an appropriate day to highlight both the extortionate price of medicines and the lack of transparency around research and development (R&D) costs.
The protest is coordinated by a coalition of over 25 health advocacy groups from 6 continents. Today’s demonstrations are being held outside offices of Pfizer, Gilead, Roche, the Tufts Center for the Study of Drug Development, and the Pharmaceutical Research and Manufacturers of America (PhRMA).
We demand an end to:
· unfair medicine pricing
· deception about research and development costs.
Instead, we want all countries to use public health safeguards to ensure better access to medicines and a global R&D agreement that would ensure better innovation for medicines.
“The public won’t be taken for fools by Big Pharma anymore! Martin Shkreli is not an outlier for gouging medicine prices! Together we’re standing up against the abusive practices of the global pharmaceutical industry, which continues to leave millions of people without access to the life-saving medicines they need”, said Luis Santiago from ACT UP.
Globally, more than two billion people do not have regular access to the critical medicines they need. This is one in three of the world's population. More than half
ACT UP 29th Anniversary Action Against Pharma Greed
On April Fools’ Day, we are protesting the extortionately high price of medicines. We’re confronting the pharmaceutical industry for its unaffordable pricing practices, leaving millions in need without access to drugs. Twenty-nine years later, we are still desperate for affordable medicines and we demand a change to the pharmaceutical system! We are a coalition of health advocacy groups confronting pharmaceutical companies which benefit from the abusive drug pricing system.
In New York, we are targeting Pfizer to demand an end to unfair drug pricing, corporate tax inversion, and deceptive information about research and development costs. Martin Shkreli is not an outlier for gouging drug prices! This is a routine practice in the pharmaceutical industry. Patients, healthcare professionals, and taxpayers will no longer tolerate such malfeasant practices!
DON’T BE FOOLED: There is no reasonable justification for current drug pricing practices!
What: ACT UP 29th Anniversary Action
When: Fri April 1 at 11:30AM
Where: Meet at Bank of America at 42nd St & 3rd Ave followed by march to Pfizer HQ
Directions: Take the 4,5,6, or 7 to Grand Central
Can’t make it? You can sign the petitions and share on social media:
Where to Get STD/HIV Tested
Confidential testing is available in all bouroughs at no, or low cost. Go to the DOH/MH website for details of times and locations. If you have problems with getting treatment, or good experiences email us at info (at) actupny.com
ACTUP and TAG to De Blasio and Bassett: No More Cuts to City HIV Testing!
Jeremiah Johnson James Krellenstein
(212) 253-7922 +1.516.865.7707
jeremiah.johnson (at) treatmentactiongroup.org james (at) krellenstein.com
ACT UP\New York and TAG to Host Town Hall Meeting to Discuss Drastic Cuts to City’s HIV Testing and STD Screening Programs
NEW YORK CITY – AUGUST 31, 2015– In response to disturbing trends in New York City’s response to the ongoing HIV and STD epidemics, ACT UP\New York and Treatment Action Group (TAG) will host a town hall meeting at the New York City LGBT Center on 13th Street in Manhattan at 6:30 PM on September 1, 2015. ACT UP and TAG seek to push the de Blasio administration to mitigate the massive citywide reduction of sexual health services in recent years, including the March 2015 closure of the Chelsea STD Clinic.
Starting in 2010, the City Government and its Health Department have significantly reduced vital services for the screening, treatment, and control of sexually transmitted diseases (STDs). This has included a drastic reduction in the number of HIV tests the City funds and performs.
The cuts resulted in a total of over 400,000 HIV tests being eliminated between 2010 and 2014, possibly resulting in the missed or delayed diagnosis of thousands of HIV-positive New Yorkers.